Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
Publication
, Journal Article
Katz, JA; Hvizdala, E; Shuster, J; Falletta, JM; Schwenn, M; Murphy, SB
Published in: J Clin Oncol
October 1993
Duke Scholars
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
October 1993
Volume
11
Issue
10
Start / End Page
2054 / 2055
Location
United States
Related Subject Headings
- Vincristine
- Prednisone
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Oncology & Carcinogenesis
- Methotrexate
- Male
- Infant
- Humans
- Female
- Daunorubicin
Citation
APA
Chicago
ICMJE
MLA
NLM
Katz, J. A., Hvizdala, E., Shuster, J., Falletta, J. M., Schwenn, M., & Murphy, S. B. (1993). Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma. J Clin Oncol, 11(10), 2054–2055. https://doi.org/10.1200/JCO.1993.11.10.2054
Katz, J. A., E. Hvizdala, J. Shuster, J. M. Falletta, M. Schwenn, and S. B. Murphy. “Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.” J Clin Oncol 11, no. 10 (October 1993): 2054–55. https://doi.org/10.1200/JCO.1993.11.10.2054.
Katz JA, Hvizdala E, Shuster J, Falletta JM, Schwenn M, Murphy SB. Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma. J Clin Oncol. 1993 Oct;11(10):2054–5.
Katz, J. A., et al. “Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.” J Clin Oncol, vol. 11, no. 10, Oct. 1993, pp. 2054–55. Pubmed, doi:10.1200/JCO.1993.11.10.2054.
Katz JA, Hvizdala E, Shuster J, Falletta JM, Schwenn M, Murphy SB. Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma. J Clin Oncol. 1993 Oct;11(10):2054–2055.
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
October 1993
Volume
11
Issue
10
Start / End Page
2054 / 2055
Location
United States
Related Subject Headings
- Vincristine
- Prednisone
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Oncology & Carcinogenesis
- Methotrexate
- Male
- Infant
- Humans
- Female
- Daunorubicin